These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 7913569)
1. New therapeutic strategies for cell-mediated autoimmune diseases. Goldman M Acta Neurol Belg; 1994; 94(2):89-91. PubMed ID: 7913569 [No Abstract] [Full Text] [Related]
2. [The current outlook in the therapy of autoimmune diseases]. Sebastiani GD; Passiu G Ann Ital Med Int; 1992; 7(2):95-101. PubMed ID: 1467130 [TBL] [Abstract][Full Text] [Related]
3. T cell targeted immunotherapy for autoimmune disease. Lee E; Sinha AA Autoimmunity; 2005 Dec; 38(8):577-96. PubMed ID: 16390811 [TBL] [Abstract][Full Text] [Related]
9. Immunological evaluation of cytokine and anticytokine immunotherapy in vivo: what have we learnt? Jorgensen C; Apparailly F; Sany J Ann Rheum Dis; 1999 Mar; 58(3):136-41. PubMed ID: 10364909 [No Abstract] [Full Text] [Related]
10. Monoclonal antibodies for the therapeutic induction of tolerance. Waldmann H; Qin S; Cobbold SP Immunol Ser; 1993; 59():85-99. PubMed ID: 8461402 [No Abstract] [Full Text] [Related]
11. [B cells as key contributors in determining the level of immune responses -B-cell-targeted therapy in patients with autoimmune diseases]. Kondo S; Akashi T; Katsuta H; Iwakiri R; Anzai K; Nagafuchi S; Niho Y; Harada M Fukuoka Igaku Zasshi; 2005 Apr; 96(4):86-92. PubMed ID: 15991605 [TBL] [Abstract][Full Text] [Related]
12. Vaccination with cytokines in autoimmune diseases. Delavallée L; Assier E; Denys A; Falgarone G; Zagury JF; Muller S; Bessis N; Boissier MC Ann Med; 2008; 40(5):343-51. PubMed ID: 18484346 [TBL] [Abstract][Full Text] [Related]
13. Cell-mediated versus humoral immunity in autoimmune diseases and their pharmacologic control with particular reference to type I diabetes mellitus. Boitard C; Bach JF Concepts Immunopathol; 1986; 3():193-224. PubMed ID: 3297326 [No Abstract] [Full Text] [Related]
14. T-cell receptor-based immunointervention in autoimmune diseases. Therapeutic use of monoclonal antibodies. Chatenoud L; Bach JF Immunol Ser; 1993; 59():101-16. PubMed ID: 7681694 [No Abstract] [Full Text] [Related]
15. Anti-class II antibody treatment in autoimmune diseases. Boitard C Immunol Ser; 1993; 59():279-93. PubMed ID: 8461393 [No Abstract] [Full Text] [Related]
16. Regulatory T cells generated ex vivo as an approach for the therapy of autoimmune disease. Horwitz DA; Zheng SG; Gray JD; Wang JH; Ohtsuka K; Yamagiwa S Semin Immunol; 2004 Apr; 16(2):135-43. PubMed ID: 15036237 [TBL] [Abstract][Full Text] [Related]
17. Immunotherapy of autoimmune disease with anti-T cell antibodies. Sriram S Concepts Immunopathol; 1989; 7():162-72. PubMed ID: 2676177 [No Abstract] [Full Text] [Related]
18. T-cell receptor peptides as immunotherapy for autoimmune disease. Gold DP; Shroeder K; Golding A; Brostoff SW; Wilson DB Crit Rev Immunol; 1997; 17(5-6):507-10. PubMed ID: 9419437 [TBL] [Abstract][Full Text] [Related]
19. Psoriasis as a T cell-mediated autoimmune disease. Barker JN Hosp Med; 1998 Jul; 59(7):530-3. PubMed ID: 9798540 [TBL] [Abstract][Full Text] [Related]